Feb 12, 2020
Bronchitis Treatment Market to Reach US$ 4.7 Bn by 2026, High Prevalence of Air Pollution Drives Growth: Transparency Market Research
Dec 02, 2019
CSA Medical, Inc. Announces European Approval for its RejuvenAir® System for COPD Patients with Chronic Bronchitis
Dec 02, 2019
Researchers from Ben-Gurion University and Cincinnati Children's Introduce Technology for Removal of Secretions from Airways
Sep 26, 2019
New Clinical Results from RheOx(TM) System for Chronic Bronchitis to be Presented at European Respiratory Society (ERS) International Congress
Sep 16, 2019
Gala Therapeutics Receives FDA Breakthrough Device Designation for the Minimally Invasive RheOx(TM) System for Chronic Bronchitis
Sep 04, 2019
Gala Therapeutics Receives CE Mark for its Minimally Invasive RheOx(TM) System for Chronic Bronchitis
Jun 19, 2019
How do vaping, the environment, lifestyle impact long-term lung health?
May 13, 2019
Chronic Obstructive Pulmonary Disease Treatment Market to Touch US$ 25,059.1 Million by 2026, Says TMR
Jan 17, 2019
Gala Enrolls First Subject at Temple Lung Center as Part of the US Early Feasibility Trial of RheOx(TM) for Chronic Bronchitis in the United States
Nov 05, 2018
Gala Enrolls First Subjects in an Early Feasibility Study of RheOx(TM) for Chronic Bronchitis in the United States
Sep 18, 2018
RejuvenAir® Metered Cryospray(TM) Shows Promise as Treatment for COPD Patients with Chronic Bronchitis
Sep 17, 2018
Gala Presents Positive Results from First-In-Human Clinical Trial of RheOx(TM) in Chronic Bronchitis at the European Respiratory Society
Aug 08, 2018
Data From First-In-Human RheOx(TM) Bronchial Rheoplasty Trial to be Presented at the European Respiratory Society
Jul 12, 2018
Gala Therapeutics Receives FDA IDE Approval for a US Early Feasibility Study of Its RheOx(TM) System to Treat Chronic Bronchitis
Mar 01, 2018
CSA Medical Announces the Completion of Treatments in the RejuvenAir Safety and Feasibility Study for patients with Chronic Bronchitis
Nov 13, 2017
Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Sep 11, 2017
CSA Medical Presented Early Clinical Data on the RejuvenAir Metered Cryospray System at the European Respiratory Society (ERS) Conference
Sep 08, 2017
CSA Medical will Host a Mini-Symposium featuring the RejuvenAir Metered Cryospray System at the European Respiratory Society (ERS) Conference